LAVAL, QC and CAMBRIDGE, England, June 2, 2023 /CNW/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced today that the Company has nominated a lead ...
PDUFA date extended by FDA from March 5, 2021 to June 5, 2021 Earnings call moved forward to Wednesday November 11th "While we are disappointed by the extension of the review period by FDA, we look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results